| Literature DB >> 27667685 |
Lenette L Lu1, Amy W Chung2, Tracy R Rosebrock3, Musie Ghebremichael4, Wen Han Yu5, Patricia S Grace4, Matthew K Schoen4, Fikadu Tafesse4, Constance Martin3, Vivian Leung3, Alison E Mahan4, Magdalena Sips6, Manu P Kumar7, Jacquelynne Tedesco4, Hannah Robinson4, Elizabeth Tkachenko4, Monia Draghi4, Katherine J Freedberg4, Hendrik Streeck8, Todd J Suscovich4, Douglas A Lauffenburger7, Blanca I Restrepo9, Cheryl Day10, Sarah M Fortune11, Galit Alter12.
Abstract
While a third of the world carries the burden of tuberculosis, disease control has been hindered by a lack of tools, including a rapid, point-of-care diagnostic and a protective vaccine. In many infectious diseases, antibodies (Abs) are powerful biomarkers and important immune mediators. However, in Mycobacterium tuberculosis (Mtb) infection, a discriminatory or protective role for humoral immunity remains unclear. Using an unbiased antibody profiling approach, we show that individuals with latent tuberculosis infection (Ltb) and active tuberculosis disease (Atb) have distinct Mtb-specific humoral responses, such that Ltb infection is associated with unique Ab Fc functional profiles, selective binding to FcγRIII, and distinct Ab glycosylation patterns. Moreover, compared to Abs from Atb, Abs from Ltb drove enhanced phagolysosomal maturation, inflammasome activation, and, most importantly, macrophage killing of intracellular Mtb. Combined, these data point to a potential role for Fc-mediated Ab effector functions, tuned via differential glycosylation, in Mtb control.Entities:
Keywords: Fc-receptors; antibodies; inflammasome; innate immunity; tuberculosis
Mesh:
Substances:
Year: 2016 PMID: 27667685 PMCID: PMC5526202 DOI: 10.1016/j.cell.2016.08.072
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582